The efficacy of H008 tablets for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial

被引：0

作者：

Tan, Niandi ^{[1
,2
]}

Liu, Xiaowei ^{[3
]}

Liu, Chengxia ^{[4
]}

Li, Shengbao ^{[5
]}

Chen, Honghui ^{[6
]}

Li, Xing ^{[7
]}

Wu, Hao ^{[8
]}

Liao, Aijun ^{[9
]}

Zhen, Yanbo ^{[10
]}

Shen, Pengzhen ^{[11
]}

Huo, Lijuan ^{[12
]}

Liu, Hongling ^{[13
]}

Shi, Ruihua ^{[14
]}

Zhang, Bingqiang ^{[15
]}

Zhan, Zhenyu

Wang, Jianning

Zhan, Qiang ^{[16
]}

Deng, Hong ^{[17
]}

Shu, Xu ^{[18
]}

Tuo, Biguang ^{[19
]}

Wang, Qizhi ^{[20
]}

Du, Shiyu ^{[21
]}

Qi, Lingzhi ^{[22
]}

Zhang, Guoxin

Peng, Qiong ^{[23
]}

Wang, Bangmao ^{[24
]}

Ye, Bin ^{[25
]}

Chen, Minhu ^{[1
,2
]}

Xiao, Yinglian ^{[1
,2
]}

机构：

[1] Sun Yat Sen Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 1, Guangzhou, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 1, Endoscopy Ctr, Guangzhou, Peoples R China

[3] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[4] Binzhou Med Univ Hosp, Taihe Hosp, Yantai, Peoples R China

[5] Taihe Hosp, Shiyan, Peoples R China

[6] Univ South China, Hosp 2, Hengyang, Peoples R China

[7] Jiangxi PingXiang Peoples Hosp, Pingxiang, Peoples R China

[8] Wenzhou Med Univ, Affiliated Hosp 7, Wenzhou, Peoples R China

[9] Univ South China, Affiliated Hosp 2, Hengyang, Peoples R China

[10] Jinan Cent Hosp, Jinan, Peoples R China

[11] Zigong Fourth Peoples Hosp, Zigong, Peoples R China

[12] Shanxi Med Univ, Hosp 1, Taiyuan, Peoples R China

[13] Luo Yang First Peoples Hosp, Luoyang, Peoples R China

[14] Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China

[15] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China

[16] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China

[17] Peoples Hosp Deyang City, Deyang, Peoples R China

[18] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China

[19] Zunyi Med Univ, Affiliated Hosp, Zunyi, Peoples R China

[20] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China

[21] China Japan Friendship Hosp, Beijing, Peoples R China

[22] Jilin Prov Peoples Hosp, Jilin, Peoples R China

[23] Anhui Med Univ, Affiliated Hosp 3, Hefei, Peoples R China

[24] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China

[25] Lishui Municipal Cent Hosp, Lishui, Peoples R China

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷

关键词：

dose-effect relationship; duodenal ulcer; H008; lansoprazole;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

0338

引用

页码：72 / 72

页数：1

共 50 条

[31] The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study
Zhuang, Qianjun
Liao, Aijun
He, Qingling
Liu, Chengxia
Zheng, Changqing
Li, Xing
Liu, Youli
Wang, Bangmao
Liu, Side
Zhang, Yan
Lin, Rong
Chen, Huixin
Deng, Min
Tang, Yanping
He, Chiyi
Dai, Weijie
Tang, Haitao
Gong, Lei
Li, Liangping
Xu, Baohong
Yang, Changqing
Zhou, Bingxi
Su, Dongxing
Guo, Qinghong
Li, Bin
Zhou, Yongjian
Wang, Xiaoyang
Fei, Sujuan
Wu, Huili
Wei, Sichen
Peng, Zhihong
Wang, Jianning
Li, Yanqing
Wang, Hong
Deng, Tianwei
Ding, Shigang
Li, Fangfang
Chen, Minhu
Xiao, Yinglian
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (04) : 658 - 666
[32] Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial
Casas, Belen Murcia
Linares, Juan Luis Carrillo
Aranda, Isabel Baquero
Villodres, Jose Rioja
Bohorquez, Vicente Merino
Jimenez, Andres Gonzalez
Rico Corral, Miguel Angel
Bosch, Ricardo
Sanchez Chaparro, Miguel Angel
Fernandez, Maria Garcia
Valdivielso, Pedro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
[33] Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial
Zhu, Xiaoyun
Li, Weinan
Yang, Yi
Li, Hengfei
Yang, Min
Zhang, Jilong
Li, Xucheng
Yan, Guangjun
Wu, Xiongfei
Zhao, Weijun
Cui, Mengdi
Yang, Xi
Hu, Xinyu
Huang, Juan
Ba, Yuanming
AGING-US, 2024, 16 (05): : 4503 - 4517
[34] A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers
Palomino, A
Hernández-Bernal, F
Haedo, W
Franco, S
Más, JA
Fernández, JA
Soto, G
Alonso, A
González, T
López-Saura, P
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (10) : 1016 - 1022
[35] Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole - A randomized, double-blind, placebo-controlled trial
Robinson, M
Lanza, F
Avner, D
Haber, M
ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) : 859 - +
[36] A randomized, double-blind, placebo-controlled trial to assess the essentiality of acid inhibitors for abdominal pain after gastroscopic mucosal biopsy
Yang, Jie
Ling-Hu, En-Qiang
Li, Hui-Kai
Feng, Xiu-Xue
Zhang, You
Bu, Bao-Guo
Wu, Bei
TURKISH JOURNAL OF GASTROENTEROLOGY, 2013, 24 (03) : 197 - 203
[37] Effect of omeprazole on symptoms of gastroesophageal reflux disease in children with cystic fibrosis. A randomized, double-blind, placebo-controlled trial
Dziekiewicz, M.
Mielus, M.
Lisowska, A.
Walkowiak, J.
Sands, D.
Radzikowski, A.
Banaszkiewicz, A.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (02) : 999 - 1005
[38] Sequential Metronidazole-Furazolidone or Clarithromycin-Furazolidone Compared to Clarithromycin-Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double-Blind Randomized Controlled Trial
Riahizadeh, Saghi
Malekzadeh, Reza
Agah, Shahram
Zendehdel, Nasrin
Sotoudehmanesh, Rasoul
Ebrahimi-Dariani, Naser
Pourshams, Akram
Vahedi, Homayoon
Mikaeli, Javad
Khatibian, Morteza
Massarrat, Sadegh
HELICOBACTER, 2010, 15 (06) : 497 - 504
[39] Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
Sugano, Kentaro
Matsumoto, Yasushi
Itabashi, Tsukasa
Abe, Sumihisa
Sakaki, Nobuhiro
Ashida, Kiyoshi
Mizokami, Yuji
Chiba, Tsutomu
Matsui, Shigeyuki
Kanto, Tatsuya
Shimada, Kazuyuki
Uchiyama, Shinichiro
Uemura, Naomi
Hiramatsu, Naoki
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (06) : 724 - 735
[40] A randomized, double blind, controlled, multi center study of Ilaparazole in the treatment of reflux esophagitis-Phase III clinical trial
Xue, Yan
Qin, Xianghong
Zhou, Liya
Lin, Sanren
Wang, Ling
Hu, Haitang
Xia, Jielai
CONTEMPORARY CLINICAL TRIALS, 2018, 68 : 67 - 71

← 1 2 3 4 5 →